Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Uniqure Ord Shs (NQ: QURE )

33.74 USD -1.74 (-4.90%)
Official Closing Price Updated: 5:09 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Uniqure Ord Shs

< Previous 1 2 3 4 5 6 7 8 9 Next >
uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease Showing Safety of Administration in NHPs and Widespread Long-Term HTT-Lowering in the Brain
Publication in Science Translational Medicine shows local striatal delivery of microRNA-gene therapy results in widespread brain huntingtin protein lowering in Huntington’s disease minipigs 
From GlobeNewswire News Releases
uniQure Announces Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in April
From GlobeNewswire News Releases
uniQure Announces Findings from Reported Case of Hepatocellular Carcinoma (HCC) in Hemophilia B Gene Therapy Program
From GlobeNewswire News Releases
uniQure Announces 2020 Financial Results and Highlights Recent Company Progress
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in March
From GlobeNewswire News Releases
uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in February
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE
Pomerantz LLP is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program
Company to hold conference call today at 8:30 a.m. ET 
From GlobeNewswire News Releases
uniQure Presents Late-Breaking Data from the HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B at the 62nd Annual Meeting of the American Society of Hematolo
From GlobeNewswire News Releases
uniQure Announces Two-Year Follow-Up Data from the Phase IIb Study of Etranacogene Dezaparvovec and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in December
From GlobeNewswire News Releases
uniQure Announces Multiple Presentations and Investor Webcast on Hemophilia B Gene Therapy Program at the 62nd American Society of Hematology (ASH) Annual Meeting
From GlobeNewswire News Releases
uniQure Announces Positive Top-Line Data from the HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B
From GlobeNewswire News Releases
uniQure Announces Clinical Data Presentations at the 62nd American Society of Hematology (ASH) Annual Meeting
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in November
From GlobeNewswire News Releases
uniQure Announces Third Quarter 2020 Financial Results and Highlights Recent Company Progress
From GlobeNewswire News Releases
uniQure Announces Enrollment of Next Two Patients in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in October
From GlobeNewswire News Releases
uniQure Announces Recommendations from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
~ Independent Data Safety Monitoring Board Recommends Proceeding with Study Enrollment; No Significant Safety Concerns Observed to Prevent Further Dosing ~ 
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in September
From GlobeNewswire News Releases
uniQure Announces Appointment of Ricardo Dolmetsch, Ph.D., as President, Research & Development
Announces Planned Departure of Sander van Deventer and Transition of Robert Gut Who is Expected to Remain on the Board of Directors 
From GlobeNewswire News Releases
uniQure Announces Second Quarter 2020 Financial Results and Highlights Recent Company Progress
From GlobeNewswire News Releases
Genespire appoints Jörn Aldag as Chairman of the Board of Directors
From GlobeNewswire News Releases
CSL Behring Agrees to Acquire Novel Late-Stage Gene Therapy Candidate for Hemophilia B Patients from uniQure
-- Unique gene therapy has the potential to be one of the first to market treatments to provide potentially long-term benefits with only one dose 
From PR Newswire
uniQure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy
From GlobeNewswire News Releases
uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
~ Milestone Marks the First-in-Human AAV Gene Therapy Trial for Huntington’s Disease ~ 
From GlobeNewswire News Releases
uniQure Announces the Appointment of Leonard E. Post, Ph.D. to its Board of Directors
From GlobeNewswire News Releases
uniQure Announces Change for its 2020 Annual General Meeting of Shareholders
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account